home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  May 20, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 461 active entries

MD Biosciences , Inc

2575 University Ave W. Suite 100
St.Paul, MN 55114
United States of America, Minnesota
Toll free: 888-USMDBIO

Phone: (651) 641 1770
Fax: (651) 641 1773

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


MD Biosciences (MDB) has assembled a specialized range of products and services to facilitate drug discovery for inflammatory and neruology diseases.
Today, MD Biosciences provides several novel models in the area of rheumatoid arthritis (RA), Asthma, IBD, Type I Diabetes, Pain, Alzheimers, as well as Multiple sclerosis and cardiac modes. The in-depth expertise in these disease models has been applied to designing protocols to assess the efficacy and required dosage of novel compounds. We have experience with both small chemical entities as well as in handling and administering biologicals. Contracted studies are designed and reviewed by MDB’s panel of internationally recognized experts and performed at one of MDB’s specialized laboratories located in St. Paul, MN (USA), Glasgow (Scotland) or in Israel . We provide a ready team of experts to tackle problems and provide solutions.

MD Biosciences recognizes that some companies may prefer doing research in-house. Many of the products and proprietary reagents used in our research are also available for purchase by all laboratories, regardless of whether MDB is contracted as a research organization. Our customers can optimize their own research process by selecting steps to be performed by MDB and research to be performed in-house. Ultimately, this option and flexibility serves to reach the customer’s goals faster.

We look forward to learning your objectives and to making proposals of how we can help you achieve your breakthroughs! 

Selected Categories:
Product Company   Service Company
- General
- General
- in vitro
- General
- Research
- Research
- Services

Last update of this entry: August 25, 2015

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.